| Developers: | IBM |
| Date of the premiere of the system: | February 2017 |
IBM Watson Imaging Clinical Review is the first cognitive imaging service developed by Watson Health.
2017: System Announcement
In February 2017, IBM announced the Watson Imaging Clinical Review, which will allow diagnosing diseases from medical images.
The cognitive computing-based platform analyzes structured and unstructured data, extracts clinically relevant information from them, and maps them to the patient "s electronic medical record. The tool is able to identify an erroneous diagnosis or administrative deficiencies in the medical history.
Simply put, if the medical report indicates a diagnosis of "aortic stenosis," Watson Imaging Clinical Review helps confirm that this diagnosis was transferred to the electronic medical record in the patient's disease section or indicated in the billing.
Watson Imaging Clinical Review can also examine in detail the results of patient examinations: ultrasound data, X-rays and other medical data that will be added to medical records and used to find patients who may urgently need surgery.
At the first stage, the technology is planned to be used to find patients with aortic valve stenosis. In the USA alone, this disease was diagnosed in 1.5 million people. Aortic stenosis occurs when there is a narrowing of the aortic valve in the heart, which prevents blood from flowing to the rest of the body and causes shortness of breath, fatigue and chest pain.
Artificial intelligence will combine images of patients with the reports of doctors to identify this disease and further treatment. In the future, the application will be able to detect the risks of developing myocardial infarction, deep vein thrombosis, cardiomyopathy (primary damage to the heart muscle that is not associated with inflammatory, tumor, ischemic genesis) and other abnormalities in the heart.
The presentation of the IBM Watson Imaging Clinical Review took place at the Healthcare Information and Management Systems Society (HIMSS) conference in Orlando (Florida, USA).[1]
The Watson supercomputer has long been used in medicine due to its ability to efficiently analyze medical images and extract information from articles in scientific publications. According to an IBM study, 80% of health data is not structured, so they are not visible to most modern information systems.
"Watson Imaging Clinical Review is an example of an AI-based address tool. Providers can use it to standardize health care in the clinic and gradually increase the required number of reproducible patient outcomes. Such a method will contribute to the development of personalized treatment based on specialized care, "said Nadim Michel Dacher, medical imaging and informatics analyst at Frost & Sullivan.
"The new cognitive tool is able to immediately help hospitals and doctors get insights they still haven't had, while adjusting to the workflows," said Ricardo C. Curie, MD, director of cardiac imaging at Baptist Health of South Florida Hospital, chairman and chief executive of Radiology Associates of South Orth.
IBM plans to expand the scope of the service with nine other cardiovascular diseases, such as myocardial infarction, heart valve abnormalities, cardiomyopathy and deep vein thrombosis.
Notes
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |